Parexel, SITS in Stroke Pact

Parexel International has established an alliance with Safe Implementation of Treatments in Stroke (SITS) International, the world’s largest network of clinical sites with specialized capabilities in the area of stroke. Through this alliance, Parexel’s clients can benefit from SITS’ access to investigator sites that are dedicated to the treatment of patients suffering from acute stroke and to the conduct of Phase II – IV stroke-related clinical studies.

“In joining forces with Parexel, SITS looks forward to furthering the growing field of stroke research and speeding the introduction of important treatments to patients,” said Nils Wahlgren, M.D., Ph.D., chairman of SITS International. “We look forward to working with Parexel to implement stroke programs throughout our expanding network of sites.” The SITS network currently comprises more than 800 investigator sites in 40 countries.

Said Mark A. Goldberg, M.D., chief operating officer, Parexel, “Our alliance with SITS is representative of our dedication to providing clients with expanded capabilities in the area of stroke, including accelerated study start-up and patient recruitment for clinical development programs. We are pleased to combine our in-depth central nervous system therapeutic area expertise with the highly specialized capabilities of SITS to help clients execute stroke-related studies more efficiently on a global basis.”